enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. AMAG Pharmaceuticals (AMAG) Upgraded to Buy: Here's Why - AOL

   www.aol.com/news/amag-pharmaceuticals-amag...

   AMAG Pharmaceuticals (AMAG) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

3. AMAG to Sell Women Healthcare Drugs, CEO Resigns, Stock Down

   www.aol.com/news/amag-sell-women-healthcare...

   For premium support please call: 800-290-4726 more ways to reach us

4. Stock market news live updates: Stocks sell off to start ...

   www.aol.com/finance/stock-market-news-live...

   All the major market averages finished higher for the week, with the S&P 500 gaining 2.5%, the Dow Jones Industrial average ending up 1.8% and the Nasdaq climbing north of 4%.

5. AMAG Pharmaceuticals (AMAG) Down 8.9% Since Last ... - AOL

   www.aol.com/news/amag-pharmaceuticals-amag-down...

   For premium support please call: 800-290-4726 more ways to reach us

6. AMAG Pharmaceuticals' (AMAG) Q2 Loss Narrower Than Expected - AOL

   www.aol.com/news/amag-pharmaceuticals-amag-q2...

   For premium support please call: 800-290-4726 more ways to reach us

7. AMAG Pharmaceuticals (AMAG) May Report Negative ... - AOL

   www.aol.com/news/amag-pharmaceuticals-amag-may...

   For premium support please call: 800-290-4726 more ways to reach us

8. The Daily Show divides viewers with jokes about murdered ...

   www.aol.com/news/daily-show-divides-viewers...

   The Daily Show’s Ronny Chieng became the first late-night host to joke about the murder of UnitedHealthcare CEO Brian Thompson.. During Thursday (December 5) night’s edition of the Comedy ...

9. AMAG Pharmaceuticals (AMAG) Reports Q1 Loss, Tops ... - AOL

   www.aol.com/news/amag-pharmaceuticals-amag...

   AMAG Pharmaceuticals (AMAG) delivered earnings and revenue surprises of -4000.00% and 5.72%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?